abstract |
Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR7, including those of Formula 1l: L1 N N.-Z X1(R 3)n Formula || and pharmaceutically acceptable salts thereof, useful in treating HIV infections. |